Medication Documentation and Monitoring Failures
Summary
The facility failed to ensure medications were administered in accordance with professional standards of practice for 5 of 6 residents reviewed for unnecessary medications. The report identified failures to document clinical indications for multiple medications, failures to monitor medications as ordered, including ordered heart rate monitoring before metoprolol administration, and failures to ensure PRN psychotropic medications had appropriate stop dates. The residents involved were R2, R5, R6, R16, and R26, each with documented diagnoses and varying levels of cognitive and functional impairment. For R2, the EMR showed calcitriol and gabapentin were administered, but physician orders, progress notes, and care plans did not document the conditions being treated or any clinical indication for either medication. R26 had multiple medications administered without documented diagnoses or clinical indications, including calcium carbonate-vitamin D, diltiazem ER, fluticasone, folic acid, montelukast, and omega-3 fatty acids. Review of R26’s physician orders, progress notes, and care plans also lacked documentation identifying the conditions being treated for these medications. Staff interviews confirmed that diagnoses or indications should be documented so staff understood why each medication was prescribed. The facility also failed to monitor ordered parameters and to document ordered assessments. R5 had an order for metoprolol tartrate with instructions to hold for SBP less than 100 or heart rate less than 55, but the MARs for January through March 2026 did not show heart rate monitoring or recording. RN-C stated the heart rate was not being monitored, and the DON stated nurses were expected to check and record blood pressure and/or heart rate as ordered. R6, R16, and R26 each had orders for orthostatic blood pressures, but the TARs and nursing documentation lacked evidence that orthostatic blood pressures were consistently monitored and documented as ordered. R6 also had PRN haloperidol and lorazepam orders without a 14-day end date or documented stop date, and the record lacked evidence that these orders were time-limited or otherwise justified in the chart.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release July 29, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.